Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas

European Journal of Gynaecological Oncology

Volumn 27, Issue 1, 2006, Pages 39-41

  Likaki Karatza, E ^a   Ravazoula, P ^a,b   Androutsopoulos, G ^a   Michail, G ^a   Batistatou, A ^a   Tzorakoleftherakis, E ^a   Kalofonos, H ^a   Kourounis, G ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Breast carcinoma; Mammographic appearance; Molecular prognostic factors

Indexed keywords

ANTIBODY; CATHEPSIN D; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MOLECULAR MARKER; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CARCINOMA; CANCER GRADING; CORRELATION COEFFICIENT; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MOLECULAR BIOLOGY; ONCOGENE NEU; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CATHEPSIN D; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MIDDLE AGED; MOLECULAR BIOLOGY; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33644942306     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cowan W.K., Kelly P., Sawan A. et al.: "The pathological and biological nature of screen-detected breast carcinomas. A morphological and Immunohistochemical study". J. Pathol., 1997, 182, 29.
2. Moezzi M., Melamed J., Vamvakas E. et al.: "Morphological and biological characteristics of mammogram-detected invasive breast cancer". Human Pathol., 1996, 27, 944.
3. Karamouzis M.V., Likaki-Karatza E., Ravazoula P. et al.: "Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors". Int. J. Cancer, 2002, 102, 86.
4. Henry J.A., McCarthy A.L., Angus B. et al.: "Prognostic significance of the estrogen-regulated protein Cathepsin D, in breast cancer: an Immunohistochemical study". Cancer, 1990, 65, 265.
5. Cowan W.K., Angus B., Henry J. et al.: "Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening". Br. J. Cancer, 1991, 64, 780.
6. Porter P.L., Gown A.M., Kramp S.G., Coltera M.D.: "Widespread p53 overexpression in human malignant tumors". Am. J. Pathol., 1992, 140, 1453.
7. Dawson A.E., Norton J.A., Weinberg D.S.: "Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry". Am. J. Pathol., 1990, 136, 1115.
8. nd edition, Vol 2. Philadelphia, JP Lippincott 1985, 1119.
9. Clark G.M., McGuire W.L.: "Steroid receptors and other prognostic factors in primary breast cancer". Semin. Oncol., 1988, 15, 20.
10. Tsutsui S., Ohno S., Murakami S. et al.: "Prognostic value of cerbB-2 expression in breast cancer". J. Surg. Oncol., 2002, 79, 216.
11. Chung Y.L., Sheu M.L., Yang S.C., Lin C.H., Yen C.V.: "Resistance to tamoxifen-indused apoptosis is associated with direct interaction between Her-2/neu and cell membrane estrogen receptor in breast cancer". Int. J. Cancer, 2002, 97, 306.
12. Henry J.A., MacGarthy A.L., Angus B. et al.: "Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer". Cancer, 1990, 65, 265.
13. Armas O.A., Gerald W.L., Lesser M.L. et al.: "Immunohistochemical detection of cathepsin D in T2N0M0 breast carcinoma". Am. J. Surg. Pathol., 1994, 18, 158.